Septerna (SEPN) CPO exercises options and sells 2,178 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Septerna, Inc.’s Chief People Officer Samira Shaikhly reported a combined option exercise and share sale. She exercised stock options to acquire 2,178 shares of Common Stock at $6.81 per share, then sold 2,178 shares at $35.18 per share in an open-market transaction.
The filing notes the sale was made under a pre-arranged Rule 10b5-1 sales plan adopted on October 31, 2025. Following these transactions, she holds 793 Common Stock shares and 20,865 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,178 shares ($76,622)
Net Sell
3 txns
Insider
Shaikhly Samira
Role
Chief People Officer
Sold
2,178 shs ($77K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,178 | $0.00 | -- |
| Exercise | Common Stock | 2,178 | $6.81 | $15K |
| Sale | Common Stock | 2,178 | $35.18 | $77K |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,865 shares (Direct, null);
Common Stock — 2,971 shares (Direct, null)
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 31, 2025. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
Key Figures
Shares sold: 2,178 shares
Sale price: $35.18 per share
Options exercised: 2,178 shares
+5 more
8 metrics
Shares sold
2,178 shares
Open-market sale of common stock
Sale price
$35.18 per share
Price for 2,178 common shares sold
Options exercised
2,178 shares
Stock options converted into common stock
Option strike price
$6.81 per share
Exercise price of stock options
Shares held after
793 shares
Common stock directly owned post-transaction
Options held after
20,865 options
Stock options remaining after exercise
10b5-1 plan adoption date
October 31, 2025
Rule 10b5-1 sales plan referenced in footnote
Option expiration
September 22, 2034
Expiration date of stock option grant
Key Terms
Rule 10b5-1 sales plan, Stock Option (Right to Buy), open-market sale, derivative exercise/conversion
4 terms
Rule 10b5-1 sales plan financial
"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person..."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an expiration date of 2034-09-22..."
open-market sale financial
"transaction_action: open-market sale with transaction_code S for Common Stock..."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion for 2,178 shares related to stock options..."
FAQ
What insider transactions did Septerna (SEPN) report for Samira Shaikhly?
Samira Shaikhly reported an option exercise and matching share sale. She exercised options for 2,178 Septerna shares at $6.81 each and sold 2,178 shares at $35.18 in an open-market trade executed under a Rule 10b5-1 plan.
What stock options did Samira Shaikhly exercise in Septerna (SEPN)?
She exercised stock options for 2,178 Septerna common shares at a $6.81 strike price. These options are part of a grant vesting monthly over 48 installments starting October 28, 2024, with the option expiring on September 22, 2034, according to the filing details.
Was the Septerna (SEPN) insider sale by the CPO pre-planned?
Yes, the sale was executed under a Rule 10b5-1 sales plan. The filing states the plan was adopted on October 31, 2025, which means the June 29, 2026 open-market sale followed a pre-arranged trading schedule rather than a discretionary, same-day decision.